Detalhe da pesquisa
1.
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.
Arterioscler Thromb Vasc Biol
; 44(5): 1086-1097, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385290
2.
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
J Hepatol
; 80(6): 941-956, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365182
3.
The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
Liver Int
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578141
4.
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD.
Liver Int
; 44(5): 1253-1264, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385564
5.
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome.
Liver Int
; 44(5): 1219-1232, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375985
6.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788059
7.
Therapeutic opportunities for the treatment of NASH with genetically validated targets.
J Hepatol
; 79(4): 1056-1064, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207913
8.
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
J Hepatol
; 79(6): 1524-1541, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730124
9.
Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
Mol Med
; 29(1): 138, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864157
10.
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 21(6): 1523-1532.e1, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421583
11.
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank.
Liver Int
; 43(6): 1247-1255, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883784
12.
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Liver Int
; 43(8): 1761-1771, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088979
13.
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
Cardiovasc Drugs Ther
; 37(5): 941-953, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567726
14.
Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction.
Int J Mol Sci
; 24(8)2023 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108628
15.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
J Hepatol
; 77(3): 596-606, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405176
16.
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
J Hepatol
; 76(5): 1001-1012, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942286
17.
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores.
Clin Gastroenterol Hepatol
; 20(3): 658-673, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091049
18.
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Gastroenterology
; 160(5): 1634-1646.e7, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347879
19.
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
J Intern Med
; 291(2): 218-223, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411351
20.
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank.
Int J Obes (Lond)
; 46(3): 486-493, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750514